May 16, 2019
The Ministry of Health, Labor and Welfare (MHLW) has drawn up optimal use promotion guidelines for Novartis Pharma’s CAR-T cell therapy Kymriah (tisagenlecleucel), which strictly define the scope of eligible patients and prerequisites for doctors and facilities that could use...read more